Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
270017775 270013842 null 97.5 Palliative (P) 2019-03-30 2019-06-23 Brentuximab N N 270011793 BRENTUXIMAB
270017776 270008102 1.82 60.35 Palliative (P) 2017-02-27 2017-03-12 Brentuximab 99 null 270011807 BRENTUXIMAB
270017777 270016583 1.7 50.6 Curative (C) 2016-09-26 2016-10-26 Capecitabine + Oxaliplatin 21day 2 N 270011813 CAPECITABINE + OXALIPLATIN
270017778 270019581 1.79 95.4 Palliative (P) 2018-05-07 2018-05-25 Capecitabine N N 270011823 CAPECITABINE
270017779 270008111 1.61 106.7 Adjuvant (A) 2015-11-01 2016-12-11 Capecitabine + Oxaliplatin 21day N N 270011847 CAPECITABINE + OXALIPLATIN
270017780 270008113 1.46 71.1 Palliative (P) 2015-09-12 2015-09-12 Capecitabine + Oxaliplatin 14day N N 270011848 CAPECITABINE + OXALIPLATIN
270017781 270008118 1.77 60.5 Curative (C) 2015-01-14 2015-02-22 CETUXIMAB 02 null 270011881 CETUXIMAB
270017782 270008121 1.8 38.1 Curative (C) 2014-06-16 2014-10-31 Cetuximab 7 day (>Cycle 2) 02 N 270011884 CETUXIMAB
270017783 270008125 1.83 63.1 Curative (C) null 2017-04-16 BEACOPP-14 Y N 270011888 BEACOPP
270017784 270008127 1.68 85 Curative (C) 2016-10-03 2017-01-24 HD EuroNet-PHL-C1 COPDAC N null 270011903 TRIAL
270017785 270008129 1.75 57.6 Curative (C) 2016-04-25 2016-05-10 Cetuximab 14 day 2 N 270011914 CETUXIMAB
270017786 270008136 1.86 66 null null 2015-12-02 Escalated BEACOPP N N 270011920 BEACOPP
270017787 270013869 1.74 119.87 Curative (C) 2017-12-08 2017-12-11 Escalated BEACOPP null N 270011928 BEACOPP
270017788 270013869 1.86 103.9 Curative (C) 2014-11-01 2015-08-16 CETUXIMAB 2 N 270011928 CETUXIMAB
270017789 270008140 0 105.8 Adjuvant (A) 2014-08-14 2014-08-16 COPP + Dacarbazine N Y 270011935 COPP + DACARBAZINE
270017790 270008146 1.67 68.4 Palliative (P) 2013-09-21 2013-11-24 Trial Unspecified 02 N 270011938 TRIAL
270017791 270008149 null 85.6 Disease modification (D) 2017-03-13 2018-04-06 CETUXIMAB 02 N 270011941 CETUXIMAB
270017792 270008151 1.58 null null 2013-11-04 2014-02-25 BEACOPP-14 N N 270011947 BEACOPP
270017793 270008155 null 53.5 Curative (C) 2015-05-01 2015-05-27 Cetuximab 14 day N N 270011962 CETUXIMAB
270017794 270008157 null 59.6 null 2014-11-26 2014-12-03 Escalated BEACOPP 2 N 270011982 BEACOPP
270017796 270008170 1.83 89.2 Palliative (P) 2013-08-23 2014-04-29 Cetuximab 7 day (>Cycle 2) 02 N 270012008 CETUXIMAB
270017797 270019586 1.6 49.4 Curative (C) 2016-01-21 2016-02-18 CETUXIMAB 02 N 270012061 CETUXIMAB
270017798 270008181 1.75 74.2 Palliative (P) 2014-04-11 2014-05-11 Cetuximab 14 day 2 N 270012076 CETUXIMAB
270017799 270008184 null 45.2 Curative (C) 2016-07-07 2016-09-10 COPP + Dacarbazine 2 N 270012085 COPP + DACARBAZINE
270017800 270013896 0 49.1 Curative (C) 2016-06-03 2016-06-06 HD EuroNet-PHL-C1 COPDAC 01 null 270012090 TRIAL
270017801 270008188 1.75 81 Curative (C) 2016-04-21 2016-04-21 HD EuroNet-PHL-C1 Relapsed IEP N N 270012091 TRIAL
270017802 270008192 null 100 null 2014-02-25 2014-05-07 HD EuroNet-PHL-C1 COPDAC N N 270012098 TRIAL
270017803 270013900 1.56 100 Adjuvant (A) null 2014-10-10 COPP + Dacarbazine 02 null 270012118 COPP + DACARBAZINE
270017804 270008201 1.86 73.8 Curative (C) 2015-04-07 2015-05-08 COPP + Dacarbazine N N 270012130 COPP + DACARBAZINE
270017805 270008203 1.79 null Palliative (P) null 2017-02-23 HD EuroNet-PHL-C1 COPDAC 2 N 270012137 TRIAL
270017806 270013904 0 null null 2016-06-17 2016-08-14 COPP + Dacarbazine 2 N 270012138 COPP + DACARBAZINE
270017807 270008205 null 39.2 Curative (C) 2016-04-23 2016-07-12 Escalated BEACOPP 01 N 270012147 BEACOPP
270017808 270008212 1.65 null Palliative (P) 2015-05-16 2015-05-16 Trial Unspecified 1 N 270012174 TRIAL
270017809 270008217 1.68 68 Adjuvant (A) 2014-06-19 2014-07-23 COPP + Dacarbazine N Y 270012187 COPP + DACARBAZINE
270017810 270008221 1.59 19.8 Curative (C) null 2018-04-05 Escalated BEACOPP N null 270012193 BEACOPP
270017811 270008227 1.76 42.7 Curative (C) 2014-03-10 2014-05-04 HD EuroNet-PHL-C1 COPDAC N null 270012207 TRIAL
270017812 270008229 null 76.5 Curative (C) 2018-08-06 2018-08-06 Escalated BEACOPP 02 N 270012217 BEACOPP
270017813 270008232 1.32 93.5 Palliative (P) 2016-12-08 2017-02-03 HD EuroNet-PHL-C1 COPDAC 01 N 270012226 TRIAL
270017814 270008234 1.81 null Curative (C) 2014-10-21 2014-10-24 COPP + Dacarbazine N N 270012227 COPP + DACARBAZINE
270017815 270008246 1.59 81 null 2014-05-02 2014-07-08 BEACOPP-14 N N 270012264 BEACOPP
270017816 270013918 1.86 68.1 null 2014-11-30 2014-12-01 Escalated BEACOPP 02 N 270012265 BEACOPP
270017817 270008251 1.83 87 Palliative (P) 2013-03-24 2014-05-28 CETUXIMAB 2 N 270012285 CETUXIMAB
270017818 270008257 1.43 68.7 Curative (C) 2015-12-10 2015-12-11 Trial Unspecified Y N 270012290 TRIAL
270017819 270013921 1.78 null Curative (C) 2016-07-28 2016-07-28 Escalated BEACOPP N null 270012302 BEACOPP
270017820 270008263 1.57 72.4 Curative (C) 2015-10-14 2015-12-13 COPP + Dacarbazine N N 270012303 COPP + DACARBAZINE
270017821 270008267 1.69 84 null 2015-06-09 2015-06-24 Trial Unspecified 2 null 270012310 TRIAL
270017822 270008271 null 77.3 Curative (C) 2014-01-23 2014-02-18 COPP + Dacarbazine N null 270012323 COPP + DACARBAZINE
270017823 270013926 1.69 49.9 Curative (C) 2015-04-08 2015-07-01 Escalated BEACOPP 02 N 270012334 BEACOPP
270017824 270008278 0 61.7 Curative (C) 2013-07-09 2013-08-08 COPP + Dacarbazine N N 270012345 COPP + DACARBAZINE
270017825 270008281 1.86 94.8 Curative (C) 2017-03-24 2017-03-30 Trial Unspecified null N 270012347 TRIAL